Summary
Following the emergence of SARS-CoV-2, early outbreak response relied on behavioral interventions. In the United States, local governments implemented restrictions aimed at reducing movements and contacts to limit viral transmission. In Pennsylvania, restrictions closed schools and businesses in the spring of 2020 and interventions eased later through the summer. In a rural Pennsylvania county, we use passive monitoring of vehicular traffic volume and mobile device derived visits to points of interest as proxies for movements and contacts. Rural areas have limited health care resources, which magnifies the importance of disease prevention. These data show the lowest levels of movement occurred during the strictest phase of restrictions, indicating high levels of compliance with behavioral intervention. We find that increases in movement correlated with increases in SARS-CoV-2 cases 9-18 days later. The methodology used in this study can be adapted to inform outbreak management strategies for other locations and future outbreaks that use behavioral interventions to reduce pathogen transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge financial support from Penn State University's Huck Institutes of the Life Sciences and the Institute for Computational and Data Sciences. The funding sources had no role in the design, execution or interpretation of the results presented here.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our work with the anonymized and aggregated data provided by SafeGraph and used in the study does not quality as human subjects research as defined by the university IRB. SafeGraph approved the use of their data for this study. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript updated to include mobile phone visit data. Movement and case data now extend to mid August 2020.
Data Availability
Most data used for this study are available from publicly available sources and are attributed in the methods section. Academic researchers must register to receive access to SafeGraph data at no charge for non-commercial purposes only here: https://www.safegraph.com/academics. SafeGraph data are anonymized and aggregated. Our work with the anonymized and aggregated data provided by SafeGraph and used in the study does not qualify as human subjects research as defined by The Pennsylvania State University's IRB. SafeGraph approved the use of their data for this study. No additional data has been generated by this study. Code to process raw data, generate models and figures are available at: https://github.com/bhartilab/covid_movement_centre
